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Recent evidence suggests that epigenetic mechanisms play a role in psychiatric diseases. 
In this study, we considered rats with neonatal ventral hippocampal lesions (NVHL) that are 
currently used for modeling neurodevelopmental aspects of schizophrenia. Contribution of 
epigenetic regulation to the effects of the lesion was investigated, using a histone deacetylase 
(HDAC) inhibitor. Lesioned or sham-operated rats were treated with the general HDAC inhibitor 
phenylbutyrate, which was injected daily from the day after surgery until adulthood. Changes in 
the volume of the lesion were monitored by magnetic resonance imaging (MRI). Anxiety was 
analyzed in the Plus Maze Test. Hypersensitivity of the dopaminergic system was evaluated by 
measuring the locomotor response to apomorphine. An associative conditioning test rewarded 
with food was used to evaluate learning abilities. The volume of the lesions expanded long 
after surgery, independently of the treatment, as assessed by MRI. Removal of the ventral 
hippocampus reduced anxiety, and this remained unchanged when animals were treated with 
phenylbutyrate. In contrast, NVHL rats’ hypersensitivity to apomorphine and deterioration of 
the associative learning were reduced by the treatment. Global HDAC activity, which was 
increased in the prefrontal cortex of lesioned non-treated rats, was found to be reversed by 
HDAC inhibition. The study provides evidence that chromatin remodeling may be useful for 
limiting behavioral consequences due to lesioning of the ventral hippocampus at an early age. 
This represents a novel approach for treating disorders resulting from insults occurring during 
brain development.
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learning deficits including those related to aging (Fischer et al., 
2007; Dash et al., 2009; Ricobaraza et al., 2009; Kilgore et al., 
2010; Peleg et al., 2010).
Neonatal lesioning of the ventral hippocampus (NVHL) in rats 
produces an animal model currently used for documenting the neu-
rodevelopmental hypothesis of schizophrenia (reviews in: Lipska, 
2004; Tseng et al., 2009). The lesion performed at the end of the first 
week of life can be checked and its progression monitored using 
magnetic resonance imaging (MRI; Angst et al., 2007; Macedo et al., 
2008, 2010; Bertrand et al., 2010; Sandner et al., 2010). Even if no 
major damage to the ventral hippocampus was found in patients, 
the approach nevertheless remains relevant since it triggers neu-
rodevelopmental changes in the dopaminergic mesocorticolimbic 
system and in the prefrontal cortex, which are now considered 
central to the model (Halim and Swerdlow, 2000). The sensitivity 
of lesioned animals to dopaminergic agents was enhanced and a 
number of basic emotional reactions and cognitive abilities were 
modified (Tseng et al., 2009).
The hippocampus and prefrontal cortex contribute to several 
cognitive processes including awareness, attention, sensory infor-
mation processing, hedonic evaluation, and memory (Nauta, 1971; 
Broersen, 2000; Rolls, 2000). These brain areas are also involved in 
the management of fear and anxiety (Shah and Treit, 2003; Degroot 
IntroductIon
A number of studies have highlighted the importance of the 
epigenetic control of gene transcription in psychiatric disorders, 
including schizophrenia (Gavin and Sharma, 2010). Epigenetic 
control involves mechanisms that regulate gene transcription 
by modifying the accessibility of genes to the transcriptional 
machinery (Szyf et al., 2008), which is achieved via complex 
mechanisms, in which DNA methylation and post-translational 
modifications of histones play a major role (Lopez-Rodas et al., 
1993). Increased DNA methylation is associated with reduced 
transcriptional activity related to tighter DNA coiling. Reduced 
transcriptional activity may also result from histone deacetyla-
tion brought about by histone deacetylases (HDACs). HDAC 
activity was found to be enhanced in patients with schizophre-
nia, especially in the prefrontal cortex (Roth et al., 2009). The 
development of a series of HDAC inhibitors as tools for modi-
fying chromatin remodeling has provided a unique opportu-
nity for the pharmacological handling of epigenetic regulation. 
The compounds have been shown to modify brain functioning, 
and to subsequently alter behavior. For instance, we have dem-
onstrated that repeated treatment with several HDAC inhibi-
tors reduced the motivation of rats to self-administer cocaine 
(Romieu et al., 2008). Others demonstrated that it reversed 
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Vehicle was likewise injected in 17 lesioned and 9 sham-operated 
animals. Rats were weighed twice a week so that the amounts to 
be injected could be adjusted. The rats were weighed again prior 
to euthanasia, at 21 weeks of age.
ImagIng technIques, mrI
Lesioned rats were subjected to three MRI sessions, at 3, 8, and 
20 weeks of age under isoflurane anesthesia. MRI was performed 
on a scanner dedicated to small animals operating at 4.7 T (TR/TE/
TEeff: 3000/30 ms/60 ms). A series of 10 slices (512 × 512 pixels) 
was generated over a 1-cm-long section of the brain rostral to the 
cerebellum–cerebrum gap. The first MRI session served to select 
rats for the subsequent experiments. Rats presenting a moderate 
bilateral lesion were included in the study. We used a full 2 × 2 
experimental design comprising nine rats per group. More specifi-
cally, we included nine lesioned rats treated with phenylbutyrate 
and nine lesioned rats that received vehicle. Two groups of nine 
sham lesioned groups, which received either phenylbutyrate or 
vehicle, were considered as controls. The other MRI sessions served 
to evaluate the broadening of the lesions with age. Lesioned areas 
were drawn on brain MRI coronal slices size-adjusted to compen-
sate for brain growth. The numbers of pixels of left and right lesion 
drawings were added together. They represent the volume estimates 
on which ANOVA was computed, with age as a within-group fac-
tor, and lesion and treatment as two between-group factors. For 
graphical representation purposes, lesion volume was divided by 
estimated brain volume for the sake of homogeneity with a previ-
ous study (Macedo et al., 2010).
LearnIng test
Rats were subjected to a conditioning procedure (Holland and 
Petrovich, 2005) which had been adapted to characterize the cog-
nitive effect of neonatal ventral hippocampal lesions (Macedo et al., 
2008).Three days prior to the beginning of the procedure, rats were 
deprived of food during the dark period. A recessed food magazine 
was placed in a wall of an experimental chamber (25 cm × 35 cm). 
It was crossed by an infrared photo-beam to detect nose pokes. A 
light visual cue and a loud speaker were placed above it. A micro-
computer delivered cues or a food reward (two 45 mg food pellets, 
Noyes rodent food pellets, Formula P, New Brunswick, NJ, USA) 
and recorded the periods of photo-beam interruption. Rats were 
first trained to feed from the food magazine. During this prelimi-
nary session, no cue was used and the reward was given randomly 
five times during a 30-min-period. Rats were then subjected to 
8 days of two 30 min-conditioning sessions, one in the morning 
and the other one in the afternoon. In each session, rats received 
either five presentations of a cue, light, or tone, lasting 10 s, imme-
diately followed by delivery of the reward (CS+ condition). They 
were also submitted to a control condition that consisted in five 
presentations of the other stimulus, with the food delivery system 
being switched off (CS− condition). All conditions were balanced: 
(1) the computer controlled four cages simultaneously, each one 
containing a rat belonging to each of the four groups; (2) for half the 
rats, the CS+ was the tone, and for the other half it was the light; (3) 
the morning/afternoon CS+/CS− sessions were spread randomly 
across the groups. The average nose-poke duration during the five 
last seconds of cue presentation was recorded and was considered 
and Treit, 2004). All these aspects are relevant for schizophrenia. 
In the present study, a fearless associative learning task was con-
ducted for testing awareness and memory (Holland and Petrovich, 
2005; Macedo et al., 2008). Fear or anxiety was evaluated using 
the classical plus maze test (Pellow and File, 1986). A D2 agonist, 
apomorphine, was administered to challenge the dopaminergic 
system which results in hyperlocomotion. Apomorphine was used 
rather than amphetamine for the following reasons: (1) it has been 
used in our previous studies (Macedo et al., 2008); (2) classical 
neuroleptic drugs show D2 antagonistic properties (Ellenbroek and 
Cools, 2002); (3) amphetamine modifies less specifically the activ-
ity of dopaminergic neuronal pathways (Schmitt and Reith, 2010); 
(4) observations based on amphetamine-elicited hyperlocomotion 
may be beset with sensitization (Featherstone et al., 2007); and (5) 
addiction to amphetamine, being itself sensitive to HDAC inhibi-
tors, may interfere with the observations (Romieu et al., 2008).
The present study aims at ascertaining whether repeated treat-
ment with the HDAC inhibitor phenylbutyrate, administered from 
the day after the lesion until adulthood, would be able to counteract 
some of the characteristic anatomical and functional brain impair-
ments found in NVHL rats.
materIaLs and methods
The methodology and protocols were approved by the French 
regional committee of ethics (CREMEAS) under the reference 
AL/01/19/10/08. All the procedures complied with the 1986 
European Council Directive (86/609/EEC), itself being in agree-
ment with the “Declaration of Helsinki.”
anImaLs
Sprague Dawley dam rats were purchased with their pups from 
Charles River, France, and housed on a 14/10-h light/dark cycle 
(lights on at 7 AM) with food and water available ad libitum, except 
during the conditioning experiment. The pups were submitted to 
a lesion or sham operation at the age of 7 days. MRI picture acqui-
sitions were performed at 3, 8, and 20 weeks, i.e., respectively in 
juvenile, young, and senior adults. Behavioral tests were conducted 
at the age of 10–20 weeks. The rats were killed in the week after the 
final MRI session. Brain sections were prepared and submitted to 
histology so that lesion size could be assessed, and the prefrontal 
cortex was dissected for biochemical investigation.
surgery
Surgical procedures were performed at PN7 under isoflurane 
anesthesia as detailed previously (Angst et al., 2007) and were 
similar to those used by others for the model (Tseng et al., 2009). 
Either 0.3 μL of ibotenic acid (Sigma, France, 10 μg/μL, pH 7.4) 
in the case of “NVHL rats,” or artificial cerebrospinal fluid in the 
case of “sham-operated rats” was infused bilaterally into the ventral 
hippocampus. Three weeks after surgery, pups were weaned and 
housed two per cage.
treatment
Sodium 4-phenylbutyrate (20 mg/kg) prepared in phosphate buff-
ered saline (PBS, pH 7.4) was injected subcutaneously on a daily 
basis, starting with the day after surgery for the lesion until the end 
of week 9 (adulthood), to 17 lesioned and 9 sham-operated rats. 
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resuLts
Body WeIght
Neonatal ventral hippocampal lesions rats weighed less than sham-
operated rats: The effect of lesion and of the interaction between 
lesion and age were significant [respectively F(1,32) = 7.00, p < 0.05 
and F(6,192) = 3.09, p < 0.01], which indicates reduced growth of 
NVHL rats. Differences in body weight could still be detected in 
21-week-old rats, with NVHL rats about 10% lighter than their 
control littermates [lesioned rats, 501 g; sham operated, 549 g; 
F(1,32) = 5.73, p < 0.05]. The treatment had no statistically sig-
nificant effect on body weight.
evoLutIon of the LesIoned BraIn areas
Photomicrographs representing MRI images of a typical lesioned 
area at 3, 8, and 20 weeks are shown at the bottom of Figure 1. 
Figure 1 also shows the relative volumes of the lesions at these 
ages. The relative volume of the lesion expanded significantly as the 
rats aged [F(2,32) = 31.0, p < 0.0001]. No statistically significant 
effect of the treatment was found [F(1,16) = 1.57], indicating that 
there was no selection bias. Interaction with age was close to the 
significance threshold [F(2,32) = 3.17, p = 0.056].
assocIatIve LearnIng
Results of the associative learning experiments, expressed as nose-
poke durations at the end of the rewarded stimulus for the antici-
pation of the reward (CS+), are shown in Figure 2. Values for the 
CS− control group remained close to baseline and are therefore 
not illustrated. Mean nose-poke durations increased between ses-
sions in all groups. It took more sessions for the untreated NVHL 
group to learn that the cue predicted food. Administering phenyl-
butyrate had no effect on the learning process in the sham-operated 
groups of rats. NVHL rats treated with phenylbutyrate attained a 
steady level that was higher than that attained by vehicle-injected 
NVHL rats, and in fewer sessions. The two criteria for adequate 
learning were statistically met: there was a difference according to 
the whether or not food was announced by the stimulus [CS+ vs. 
an index of anticipation of the reward (Holland and Petrovich, 
2005). It constituted the dependent variable of an ANOVA, where 
the associative feature (CS+ vs. CS−) and series of daily sessions 
were two within-group factors, and the lesion and treatment being 
two between-group factors.
LocomotIon under apomorphIne
Locomotion was evaluated in eight identical test cages 
(30 cm × 40 cm). They were different from the home cages in many 
respects (different shape, dimmer light, silent environment, walls 
with black stripes). A passive infrared detector (IRP 124, Talco, 
France) was used to monitor activity during consecutive 5 min-
periods over 1 h. The detector comprised a  gallium- arsenide 
 infrared sensitive surface placed behind a Fresnel lens and reacted 
to the heat emitted by the rat. The lens determined 8 × 3 sectors. 
Each transition from one sector to another provided an electric 
pulse to the computer interface. Measurements started imme-
diately after the rats had been subcutaneously injected with an 
apomorphine solution prepared in saline (0.35, 0.70, or 1.40 mg/
kg). In order to minimize sensitization, rats were tested at increas-
ing dosage, and the successive tests were separated by at least a 
2-week-period. Results were submitted to an ANOVA, with the 
successive series of 5 min measurements and the dose of apo-
morphine as two within-group factors, and the lesion and treat-
ment as two between-group factors. Noteworthy, all rats were 
subjected to the same treatment schedule so that any differential 
result in the following test cannot be attributed to the effect of 
apomorphine per se.
anxIety, eLevated pLus maze test
As a last behavioral experiment, the rats were subjected to the stand-
ard Elevated Plus Maze Test for anxiety (Pellow and File, 1986). It is 
made of two closed arms (i.e., surrounded by walls), orthogonal to 
two open arms. The rats were placed on a central platform facing 
an open arm. Their position was recorded for 30 min. The time 
spent in the open arms and the number of entries were submitted to 
ANOVAs, with the arms (open vs. closed) as a within-group factor, 
and the lesion and treatment as two between-group factors.
post-mortem hIstoLogy and hdac tItratIon
The rats were given an overdose of pentobarbital (1 mL Doléthal, 
Vétoquinol, France). Their brain was removed and a 3-mm-thick 
slice cut away, the upper surface being 1 mm rostral to the corpus 
callosum (coronal slice extending from Bregma – 0.3 to 2.7 mm). 
This slice was then placed on a stainless steel plate at 4°C, and the left 
medial prefrontal cortical area containing the pre- and infra-limbic 
cortex, the cingulate cortex, and part of the secondary motor cortex 
was cut out. It was immediately immersed into liquid nitrogen 
and processed for HDAC activity measurement the next day. The 
remaining caudal brain was fixed by immersion in 4% formalin and 
used to verify the lesion on 25-μm-thick sections stained with Cresyl 
violet. Total nuclear HDAC activity was measured with the Fluor 
de Lys assay system (Biomol, Plymouth, PA, USA), as described 
previously (Romieu et al., 2008). Deacetylase activity was expressed 
as arbitrary fluorescence units per minute per milligram of protein 
and subjected to an ANOVA, with the lesion and treatment as two 
between-group factors.
Figure 1 | Volume of the neonatal ventral hippocampal lesion expressed 
relative to brain size at the age of 3, 8, and 20 weeks. Values represent 
means (±SEM) of the relative volume of the lesion in rats that were treated 
with 20 mg/kg phenylbutyrate (PhB: blue squares) or the same volume of the 
vehicle PBS (Veh: open red squares). Photomicrographs at the bottom show 
three RMI pictures of the lesion at the three ages considered, taken from a rat 
belonging to the phenylbutyrate-treated group of rats. Lesioned areas are 
marked with arrows.
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eLevated pLus maze
Results from the Elevated Plus Maze test are shown in Figure 4. 
Compared with the control groups, rats from the NVHL group 
spent more time in the open arms and went into them more 
frequently. As for the time spent in the open arms, the signifi-
cant factors were the lesion [F(1,32) = 10.6, p < 0.01], the arms 
[F(1,32) = 9.43, p < 0.01], and the interaction between the two fac-
tors [F(1,32) = 6.22, p < 0.05]. Treatment with the HDAC inhibitor 
did not influence the test results [F(1,32) = 0.75]. Concerning the 
number of open arm entries, the significant factors were the lesion 
[F(1,32) = 7.02, p < 0.05], the arms [F(1,32) = 4.99, p < 0.05], and 
the interaction between the two factors [F(1,32) = 9.55, p < 0.01]. 
The treatment had no influence on the results [F(1,32) = 0.01].
hdac assay
Figure 5 illustrates the global HDAC activity in nuclear extracts 
derived from the prefrontal cortex of the same four groups of rats. 
HDAC activity was found to be increased in lesioned vehicle-treated 
rats. Repeated treatment with phenylbutyrate restored activity to 
the level found in sham-operated animals. A significant interaction 
was found between the lesion and the treatment [F(1,30) = 5.10, 
p < 0.05). It is worth noting that both the lesion and the treatment 
factors revealed a significant effect per se [F(1,30) = 9.86, p < 0.01 
and F(1,30) = 13.4, p < 0.001, respectively].
hIstoLogy
Figure 6 shows that there was no selection bias between phenylbu-
tyrate and vehicle treated lesioned rats. The ventral hippocampus 
appeared to be severely damaged, except for dorsal and caudal ven-
tral endings. Neither the dorsal hippocampus, nor the entorhinal 
cortex was damaged.
dIscussIon
Histone deacetylase inhibition in rats reduced several long-term 
consequences of a neonatal ventral hippocampal lesion, such as 
provoked locomotion and alteration of a rewarded learning, but not 
CS−: F(1,32) = 63.8, p < 0.0001], and a progression was observed 
from session to session [F(7,224) = 21.0, p < 0.0001]. The global 
effect of the lesion was significant [F(1,32) = 7.06, p < 0.05) and 
interacted with the effect of treatment [F(1,32) = 5.03, p < 0.05). 
This is evidence that the treatment was more or only efficient in 
NVHL rats, as seen in Figure 2. Interaction between the effect of 
the lesion and the changes between the sessions was also significant 
[F(7,224) = 2.81, p < 0.01), which indicates that the learning process 
did not follow the same timeline in lesioned rats as in their sham-
operated controls. It is noteworthy that the mean final performance 
of non-treated NVHL rats was not as good as the other groups. This 
had been already observed previously (Macedo et al., 2008).
apomorphIne Induced LocomotIon
No difference was noticed for the lowest apomorphine dose 
(0.35 mg/kg). Figure 3 shows the locomotion observed during 1 h 
after subcutaneous injection of the highest dose of apomorphine 
(1.4 mg/kg). For this apomorphine dose, the non-treated NVHL 
group displayed high activity, whereas the NVHL group of rats 
treated with phenylbutyrate showed substantially the same level 
of activity as the control groups. The test’s timeline was significant 
[F(11,352) = 25.7, p < 0.0001], and lesion interacted significantly 
with it [F(11,352) = 2.36, p < 0.01), as well as with the apomorphine 
dose [F(22,704) = 6.96, p < 0.0001]. Statistical analysis also revealed 
a significant global effect of lesion [F(1,32) = 4.38, p < 0.05], and of 
the apomorphine dose [F(2,64) = 14.7, p < 0.0001] and a significant 
interaction between the two factors [F(2,64) = 3.58, p < 0.05]. These 
data denote a dose-dependent differential reactivity to apomor-
phine between lesioned and control rats, typical of this animal 
model. They also reveal a significant triple interaction between 
lesion, dose of apomorphine, and treatment [F(2,64) = 4.99, 
p < 0.01], demonstrating a differential reactivity to apomorphine 
when NVHL rats were administered phenylbutyrate.
Figure 2 | effect of the phenylbutyrate treatment on lesioned rats in the 
associative learning test. The graph shows the duration of nose poking in 
the food magazine during the 5-s before food was delivered (ceiling = 5 s). The 
X-axis depicts the sequence of daily training sessions in which 10 s of the cue 
preceded food delivery. The Y-axis presents the mean (and SEMs) nose-poke 
duration for each daily session. Sham-operated rats (dotted lines) were treated 
with 20 mg/kg phenylbutyrate (dark circles) or vehicle (open circles). Lesioned 
rats (full lines) were treated with phenylbutyrate (blue squares) or PBS (open 
red squares).
Figure 3 | effect of the phenylbutyrate treatment on the locomotor 
activity elicited by apomorphine. Locomotor activity corresponding to beam 
crossings was plotted every 5 min following a subcutaneous injection of 
1.4 mg/kg apomorphine with SEMs. The symbols used are those described in 
the legend to Figure 2. The arrow marks the time of injection.
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be compared to the gradual cortical shrinkage observed in some 
elderly schizophrenic patients (Cahn et al., 2009). From a theoreti-
cal point of view, it indicates that the NVHL model comprises a 
gradual degenerative aspect. It is worth noting that the effect of 
the treatment with phenylbutyrate nearly reached statistical sig-
nificance in slowing down this evolution. The possibility that the 
treatment affected this macroscopic criterion of brain atrophy can 
therefore not be ruled out and deserves further investigation.
emotIonaL reactIvIty
In the Elevated Plus Maze Test, rats spent more time in the open 
arms and went more often into them than their controls, which is 
usually interpreted as denoting reduced anxiety (Pellow and File, 
1986). Reduced anxiety appears to be a general issue following 
damage to the neuronal network to which the ventral hippocam-
pus belongs (Shah and Treit, 2003; Wood et al., 2003; Beninger 
et al., 2009). Even when the network was temporally switched off, 
for instance by means of tetrodotoxin injection into the ventral 
hippocampus, rats were less sensitive to fear (Degroot and Treit, 
2004). Since similar anxiolytic effects were also reported when the 
medial prefrontal cortex was lesioned (Shah and Treit, 2003), one 
can assume that optimal management of emotions requires the 
integrity of the hippocampus–prefrontal cortex interplay that had 
been damaged and was neither spontaneously repaired nor with 
the treatment.
hyperLocomotIon under apomorphIne
It has been well documented that apomorphine elicits hyperloco-
motion in NVHL rats (Schroeder et al., 1999). At the doses used 
here, some repetitive behavioral activities were observed in addi-
tion to mere locomotion. They consisted of repetitive oro-facial 
activity (sniffing around the edges of the cage, licking its bottom, 
carrying, and gnawing droppings), i.e., activity that was adapted 
to targets present in the cage, which is not observed in the case 
other effects of the lesion, such as reduced anxiety or anatomical 
changes to the brain. These are well documented outcomes of the 
lesion. Confirming such earlier observations ensures that there was 
no bias in our experimental strategy. We also replicated some of 
the less documented effects, confirming and expanding them. For 
instance, we confirmed that the size of the lesion increased until 
puberty (Bertrand et al., 2010; Sandner et al., 2010). The lesions 
continued extending after puberty, albeit at a lower rate.
evoLutIon of the LesIons
The broadening of the lesioned area has been attributed to the 
degeneration of other brain areas as an indirect consequence of the 
lesion (Halim and Swerdlow, 2000; Sandner et al., 2010), which can 
Figure 4 | Absence of effect of the phenylbutyrate treatment in the Plus 
Maze test. Presence of the rats in open arms is shown in the left bar graph, 
and number of entries into the arms in the right bar graph. Each bar represents 
the mean ± SEM. The same four groups of rats described in the legends to 
Figures 2 and 3 were tested. Blue bars denote the results from rats injected 
with phenylbutyrate and open bars the results from vehicle-injected rats. In 
each graph, the two left bars represent data from sham-operated rats 
whereas the two right bars show results obtained with NVHL rats.
Figure 5 | effect of phenylbutyrate on nuclear HDAC activity in the 
prefrontal cortex. Total HDAC activity was measured in the nuclear fraction 
prepared from samples of prefrontal cortex, using a fluorescent activity assay. 
Each bar represents the mean ± SEM of arbitrary fluorescence units per 
minute and per milligram of protein. Blue bars show the results obtained from 
rats injected with phenylbutyrate, and open bars from vehicle-injected rats.
Figure 6 | effect of the phenylbutyrate treatment on the histological 
aspect of NVHL rats. Photomicrographs of coronal sections prepared at the 
end of the experiments show the lesions at their largest. Arrows mark the 
dorsal and ventral end of each lesion. No significant difference can be 
observed between lesions in the eight sections at the left part 
(phenylbutyrate-treated rats) and lesions in the eight sections at the right part 
(control vehicle-injected rats).
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of amphetamine-induced stereotypy. It would probably be worth 
studying the ontogenesis of such behaviors in NVHL rats, as they 
were considered to represent developmental landmarks (Lepekhina 
and Tsitsurina, 2007) and the hypersensitive locomotor activity in 
response to dopaminergic agents appears only when rats become 
adult (Flores et al., 1996; Wood et al., 1997). At the dose of 0.7 mg/ kg 
apomorphine, hyperlocomotion was only partially reversed by the 
phenylbutyrate treatment, whereas it was totally reversed for the 
higher dose of 1.4 mg/kg. This somewhat paradoxical observa-
tion might tentatively be explained by two factors that could have 
affected the results obtained for the highest dose: hyperlocomotion 
was increased in all the groups boosting the baselines and exces-
sive stereotypy may have reduced locomotion. Hypersensitivity to 
dopaminergic agents occurs when the prefrontal cortex is deprived 
of its hippocampal afferent neurons (Lipska et al., 1998). Regulation 
of neuronal activity in the nucleus accumbens by the prefrontal 
cortex is modified, resulting in the alteration of the sensitivity to 
dopaminergic drugs (Goto and O’Donnell, 2004). This behavioral 
aspect and the previously discussed associative conditioning were 
overcome by administering phenylbutyrate most probably because 
of the plasticity occurring in the still immature frontal cortex. This 
plasticity has already been successfully reversed, but with different 
means, namely an additional lesion of the prefrontal cortex (Klein 
et al., 2008). The precise description of the alterations that are taking 
place in the frontal cortex requires further studies. It might not only 
involve plastic changes in existing neurons, but also neurogenesis 
during the early age of the rat (Inta et al., 2008). A strong argu-
ment for this is that sodium butyrate has been shown to stimulate 
neurogenesis (Kim et al., 2009).
motIvatIon and LearnIng
Neonatal ventral hippocampal lesions rats weighed 10% less than 
their sham-operated littermates, as was the case in Chrapusta 
et al. (2003). The ventral hippocampus may be involved in regula-
tion of food intake, especially when hedonic aspects are involved 
(Davidson et al., 2009). A contribution of the ventral hippocam-
pus in the hedonic dimension of feeding would explain the lower 
body weight of NVHL rats. Nevertheless, participation of another 
behavioral abnormality or of some endocrine modification cannot 
be ruled out (Clifton et al., 1998) and are presently under investiga-
tion in our laboratory. Changes in the attitude of rats toward food 
may also explain the modification observed in the learning test 
used in this study. But aversively motivated learning was found to 
be impaired also in NVHL rats, indicating that it was probably a 
general aspect of learning that was modified by the lesion (Angst 
et al., 2007). Whatever the mechanism, our data highlight the fact 
that the modified behavior was completely countered by the phe-
nylbutyrate treatment.
prefrontaL hdac actIvIty
It is well known that indirect consequences of neonatal ventral 
hippocampal lesioning take place essentially in the prefrontal cor-
tex (Goto and O’Donnell, 2004; Flores et al., 2005; Tseng et al., 
2006, 2008; François et al., 2009). Adaptations to the prefrontal 
altered brain circuitry probably involve tremendous modifications 
in gene expression, in which epigenetic regulation is known to play 
a growing role (Colvis et al., 2005). When measuring total HDAC 
activity in the prefrontal cortex, we found it to be increased in 
lesioned vehicle-treated rats. It is striking that enhanced enzymatic 
activity was effective for as long as 4 months after the lesion was 
performed. Hence, it probably results from a novel equilibrium 
reached between acetylation and deacetylation processes in order to 
maintain the gene transcription at a crucial level for sustaining the 
functional impairment in the cortex. The treatment probably modi-
fies the transcription of some specific genes. It remains to be deter-
mined though which genes are mostly affected. In a recent study, 
we demonstrated that genes encoding several HDACs are them-
selves under the control of HDAC inhibitors (Host et al., 2010). In 
turn, permanence of the enzymatic activity over a long period may 
account, at least partially, for the great stability of epigenetic regula-
tions generally observed (Fraga et al., 2005). As expected, repeated 
treatment with a general HDAC inhibitor from the day following 
lesion until adulthood restored the activity in the prefrontal cortex 
back to the level found in sham-operated animals. In contrast, the 
inhibitor only slightly decreased HDAC activity in the prefrontal 
cortex of sham-operated rats, probably because the enzymes sensi-
tive to phenylbutyrate are not sufficiently active in the cortex of 
normal adult rats for the inhibition to be discernible. It is worth 
noting that the increased HDAC activity found in NVHL rats paral-
lels the increased activity found in post-mortem brain samples of 
schizophrenic patients (Sharma et al., 2008; Akbarian, 2010). This 
was correlated with a reduced expression in the prefrontal cortex 
of the GAD67 gene, which is known to be controlled by epigenetic 
mechanisms (Akbarian et al., 2005; Huang et al., 2007; Costa et al., 
2009). If this type of regulation concerns a great many genes, it may 
help to explain the broad array of clinical, neuroanatomical, and 
molecular abnormalities reported in patients with schizophrenia, 
some of which are observable in NVHL rats.
data InterpretatIon LImIts
Some aspects of the work, which should not be over-interpreted, need 
further investigation. Firstly, like many other HDAC inhibitors, phenyl-
butyrate displays no selectivity toward the various class I and II HDACs; 
in addition, it may have other targets than the HDACs (Scaglia, 2010). 
Additional HDAC inhibitors displaying greater selectivity should be 
tested using a similar experimental strategy, or better, after having 
determined the critical duration of the treatment. A second remark 
concerns the period of life during which the treatment will be efficient. 
We hypothesized that similar results would be obtained when treating 
rats once they reached adulthood, as is the case in some other diseases 
(Fischer et al., 2007; Yildirim et al., 2008; Ricobaraza et al., 2009; Host 
et al., 2010; Kilgore et al., 2010; Peleg et al., 2010). We therefore con-
ducted a similar experiment to the one presented here, except that 
the rats were only treated 1 week before and during the tests. While 
we reproduced exactly the effect of the lesion, phenylbutyrate-treated 
rats behaved like their vehicle-injected controls in all the tests (data not 
shown). Interestingly, that phenylbutyrate treatment was not efficient 
when given to adult animals argues against the possibility that the 
effects, observed when treatment followed immediately the lesioning, 
resulted from some trivial non-specific consequence of the inhibitor. 
Finally, another uncontrollable limiting factor arises from the interac-
tion of the consequences of the treatment with determinant aspects of 
the experiments that cannot be avoided, such as maternal care (Wood 
et al., 2003) or stress (Laplante et al., 2004).
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